Pfizer Inc. (ETR:PFE)

Market Cap	125.87B
Revenue (ttm)	53.69B +3.9%
Net Income	8.41B +131.2%
EPS	1.48 +131.9%
Shares Out	n/a
PE Ratio	14.97
Forward PE	8.99
Dividend	1.49 (6.79%)
Ex-Dividend Date	Jan 23, 2026

Volume	39,147
Average Volume	63,046
Open	22.02
Previous Close	22.32
Day's Range	21.74 - 22.04
52-Week Range	18.57 - 26.10
Beta	0.43
RSI	50.33
Earnings Date	Feb 3, 2026

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1849
• Employees: 81,000
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: PFE

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD